Golden State Equity Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Golden State Equity Partners’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Hold	19,380	–	–	0.14%	179
2025 Q4	$1.53M	Hold	19,380	–	–	0.25%	83
2025 Q3	$1.42M	Hold	19,380	–	–	0.24%	99
2025 Q2	$986K	Hold	19,380	–	–	0.18%	138
2025 Q1	$873K	Hold	19,380	–	–	0.17%	153
2024 Q4	$801K	Buy	19,380 +18,080	+1,391%	+$753K	0.15%	160
2024 Q3	$50.7K	Sell	1,300 -18,630	-93%	-$743K	0.03%	377
2024 Q2	$681K	Buy	+19,930	New	+$523K	0.14%	163
2023 Q4	$559K	Buy	18,930 +950	+5%	+$28.8K	0.14%	172
2023 Q3	$568K	Hold	17,980	–	–	0.16%	152
2023 Q2	$465K	Hold	17,980	–	–	0.13%	192
2023 Q1	$432K	Buy	+17,980	New	+$410K	0.23%	106
2022 Q1	$412K	Hold	18,730	–	–	0.21%	121
2021 Q4	$299K	Buy	+18,730	New	+$291K	0.15%	128

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Golden State Equity Partners's MIRM Position: Q1 2026 in Review

Golden State Equity Partners held its Mirum Pharmaceuticals (MIRM) position steady in Q1 2026 at 19,380 shares worth $1.79M. The position accounts for 0.14% of the portfolio, ranked #179.

Golden State Equity Partners first reported a position in MIRM in Q4 2021 and has held it in 14 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

Golden State Equity Partners held 19,380 shares of Mirum Pharmaceuticals worth $1.79M as of Q1 2026.
Golden State Equity Partners left its Mirum Pharmaceuticals share count unchanged in Q1 2026.
Mirum Pharmaceuticals made up 0.14% of Golden State Equity Partners's portfolio in Q1 2026, its #179 holding.
Golden State Equity Partners first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.